Stephen Thein
Overview
Explore the profile of Stephen Thein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunz D, Dauvilliers Y, Benes H, Garcia-Borreguero D, Plazzi G, Seboek Kinter D, et al.
CNS Drugs
. 2022 Dec;
37(1):93-106.
PMID: 36484969
Background And Objective: Daridorexant is a dual orexin receptor antagonist for the treatment of insomnia. In two phase III, 12-week studies in patients with insomnia disorder, daridorexant improved sleep and...
2.
Rosenberg R, Abaluck B, Thein S
J Clin Sleep Med
. 2022 Aug;
18(12):2837-2844.
PMID: 35975547
Study Objective: Obstructive sleep apnea is a common and serious sleep disorder for which treatment remains challenging due to lack of adherence to approved therapies. Previous pharmacological studies addressing sleep-related...
3.
Coric V, Salloway S, van Dyck C, Dubois B, Andreasen N, Brody M, et al.
JAMA Neurol
. 2015 Sep;
72(11):1324-33.
PMID: 26414022
Importance: Early identification of Alzheimer disease (AD) is important for clinical management and affords the opportunity to assess potential disease-modifying agents in clinical trials. To our knowledge, this is the...
4.
Coric V, van Dyck C, Salloway S, Andreasen N, Brody M, Richter R, et al.
Arch Neurol
. 2012 Aug;
69(11):1430-40.
PMID: 22892585
Objective: To assess the safety, tolerability, and pharmacokinetic and pharmacodynamic effects of the -secretase inhibitor avagacestat in patients with mild to moderate Alzheimer disease (AD). Design: Randomized, double-blind, placebo-controlled,24-week phase...